Effect of Deep Brain Stimulation in The Ventral Tegmental Area on Neuronal Activity in Local and Remote Brain Regions in Kindled Mice.
Deep Brain Stimulation
Epilepsy
Pentylenetetrazole
Ventral tegmental area
Journal
Cell journal
ISSN: 2228-5806
Titre abrégé: Cell J
Pays: Iran
ID NLM: 101566618
Informations de publication
Date de publication:
01 Apr 2023
01 Apr 2023
Historique:
received:
10
07
2022
medline:
21
5
2023
pubmed:
21
5
2023
entrez:
21
5
2023
Statut:
epublish
Résumé
The mechanisms behind seizure suppression by deep brain stimulation (DBS) are not fully revealed, and the most optimal stimulus regimens and anatomical targets are yet to be determined. We investigated the modulatory effect of low-frequency DBS (L-DBS) in the ventral tegmental area (VTA) on neuronal activity in downstream and upstream brain areas in chemically kindled mice by assessing c-Fos immunoreactivity. In this experimental study, 4-6 weeks old BL/6 male mice underwent stereotaxic implantation of a unilateral stimulating electrode in the VTA followed by pentylenetetrazole (PTZ) administration every other day until they showed stage 4 or 5 seizures following 3 consecutive PTZ injections. Animals were divided into control, sham-implanted, kindled, kindled-implanted, L-DBS, and kindled+L-DBS groups. In the L-DBS and kindled+L-DBS groups, four trains of L-DBS were delivered 5 min after the last PTZ injection. 48 hours after the last L-DBS, mice were transcardially perfused, and the brain was processed to evaluate c-Fos expression by immunohistochemistry. L-DBS in the VTA significantly decreased the c-Fos expressing cell numbers in several brain areas including the hippocampus, entorhinal cortex, VTA, substantia nigra pars compacta, and dorsal raphe nucleus but not in the amygdala and CA3 area of the ventral hippocampus compared to the sham group. These data suggest that the possible anticonvulsant mechanism of DBS in VTA can be through restoring the seizure-induced cellular hyperactivity to normal.
Identifiants
pubmed: 37210648
doi: 10.22074/cellj.2023.557500.1058
pmc: PMC10201359
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
273-286Références
Neuron. 2005 Jun 2;46(5):703-13
pubmed: 15924857
J Neurosci. 2003 Feb 1;23(3):867-75
pubmed: 12574415
PLoS One. 2011 May 03;6(5):e19415
pubmed: 21559295
Behav Brain Res. 2017 Jul 14;330:1-7
pubmed: 28506618
Brain Behav Immun. 2018 Feb;68:248-260
pubmed: 29080683
Dev Reprod. 2015 Jun;19(2):61-7
pubmed: 27004262
J Neurosci. 2004 Jun 2;24(22):5131-9
pubmed: 15175382
Epilepsy Res. 2023 Jan;189:107073
pubmed: 36584482
J Neurosci. 2017 Aug 30;37(35):8315-8329
pubmed: 28739583
Brain Res. 2020 Jul 1;1738:146820
pubmed: 32251663
Nat Neurosci. 2003 Sep;6(9):968-73
pubmed: 12897785
Neuroscience. 2008 Apr 9;152(4):1024-31
pubmed: 18355970
N Engl J Med. 2001 Aug 2;345(5):311-8
pubmed: 11484687
J Comp Neurol. 2014 Oct 1;522(14):3308-34
pubmed: 24715505
Biomed Res Int. 2014;2014:876712
pubmed: 24605339
Brain Res. 1994 Jan 21;634(2):203-13
pubmed: 8131070
Am J Physiol. 1998 Jun;274(6):H2046-52
pubmed: 9841531
Epileptic Disord. 2002 Dec;4 Suppl 3:S9-22
pubmed: 12495871
J Neurophysiol. 2013 Jan;109(1):171-82
pubmed: 23054599
Epilepsy Behav. 2019 Jun;95:51-55
pubmed: 31026782
Synapse. 1996 Feb;22(2):159-94
pubmed: 8787131
Epilepsy Behav. 2010 Jan;17(1):6-22
pubmed: 19926525
Exp Brain Res. 1988;73(1):69-77
pubmed: 3208862
Epilepsia. 2005 Jan;46(1):1-7
pubmed: 15660762
Front Behav Neurosci. 2011 Aug 02;5:45
pubmed: 21852968
Neuroscience. 1982 Jul;7(7):1779-83
pubmed: 6181433
Ann Neurol. 2013 Aug;74(2):223-31
pubmed: 23613463
eNeuro. 2020 May 20;7(3):
pubmed: 32321772
Epilepsia. 2005 Apr;46(4):470-2
pubmed: 15816939
Int J Neuropsychopharmacol. 2012 Aug;15(7):957-64
pubmed: 21745437
EMBO Mol Med. 2019 Apr;11(4):
pubmed: 30862663
Neuroscience. 2008 Apr 22;153(1):196-213
pubmed: 18358616
Epilepsia. 2012 Jan;53(1):147-56
pubmed: 22150779
Annu Rev Neurosci. 2007;30:289-316
pubmed: 17376009
Adv Pharmacol Sci. 2012;2012:182671
pubmed: 23008702